| Product NDC: | 16252-598 |
| Proprietary Name: | Lamotrigine |
| Non Proprietary Name: | lamotrigine |
| Active Ingredient(s): | 25 mg/1 & nbsp; lamotrigine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, CHEWABLE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16252-598 |
| Labeler Name: | Cobalt Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076928 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090729 |
| Package NDC: | 16252-598-01 |
| Package Description: | 100 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (16252-598-01) |
| NDC Code | 16252-598-01 |
| Proprietary Name | Lamotrigine |
| Package Description | 100 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (16252-598-01) |
| Product NDC | 16252-598 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lamotrigine |
| Dosage Form Name | TABLET, CHEWABLE |
| Route Name | ORAL |
| Start Marketing Date | 20090729 |
| Marketing Category Name | ANDA |
| Labeler Name | Cobalt Laboratories |
| Substance Name | LAMOTRIGINE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |